Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Geurts, Marjolein"'
Autor:
Vieito M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Universidad Autonoma de Barcelona, Barcelona, Spain., Simonelli M; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Milan, Italy., de Vos F; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Moreno V; START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Geurts M; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Lorenzi E; IRCCS Humanitas Research Hospital, Milan, Italy., Macchini M; Department of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., van den Bent MJ; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Del Conte G; Department of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., de Jonge M; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Martín-Soberón MC; Neuro-Oncology Unit, Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Amoroso B; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain., Sanchez-Perez T; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain., Zuraek M; Bristol Myers Squibb, San Francisco, CA, USA., Hanna B; Bristol Myers Squibb, Princeton, NJ, USA., Aronchik I; Bristol Myers Squibb, San Francisco, CA, USA., Filvaroff E; Bristol Myers Squibb, San Francisco, CA, USA., Chang H; Bristol Myers Squibb, San Francisco, CA, USA., Mendez C; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain., Arias Parro M; Bristol Myers Squibb, Boudry, Switzerland., Wei X; Bristol Myers Squibb, Princeton, NJ, USA., Nikolova Z; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain., Sepulveda JM; Hospital Universitario 12 de Octubre, Madrid, Spain.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2022 Oct 28; Vol. 4 (1), pp. vdac146. Date of Electronic Publication: 2022 Oct 28 (Print Publication: 2022).
Autor:
Swildens KX; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sillevis Smitt PAE; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van den Bent MJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., French PJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Geurts M; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2022 Jun 07; Vol. 4 (1), pp. vdac087. Date of Electronic Publication: 2022 Jun 07 (Print Publication: 2022).